Key Financial Data Of Reporting Company

Daito Pharmaceutical Co., Ltd. - Filing #7716453

Concept 2018-06-01 to
2018-11-30
2018-09-01 to
2018-11-30
As at
2018-11-30
As at
2018-05-31
2017-06-01 to
2018-05-31
As at
2017-11-30
2017-06-01 to
2017-11-30
2017-09-01 to
2017-11-30
Key financial data of reporting company
Business results of reporting company
Net sales
20,145,447,000 JPY
39,875,983,000 JPY
20,454,187,000 JPY
Ordinary profit (loss)
2,368,697,000 JPY
4,244,028,000 JPY
2,304,443,000 JPY
Net assets
29,953,133,000 JPY
28,495,554,000 JPY
27,327,498,000 JPY
Total assets
48,565,498,000 JPY
46,898,563,000 JPY
47,370,920,000 JPY
Basic earnings (loss) per share
133.74
71.42
243.08
126.82
73.02
Diluted earnings per share
Equity-to-asset ratio
0.608 xbrli:pure
0.598 xbrli:pure
0.567 xbrli:pure
Net cash provided by (used in) operating activities
1,977,938,000 JPY
5,465,342,000 JPY
1,613,239,000 JPY
Net cash provided by (used in) investing activities
-1,712,171,000 JPY
-3,833,093,000 JPY
-2,004,371,000 JPY
Net cash provided by (used in) financing activities
-195,972,000 JPY
-1,543,585,000 JPY
472,198,000 JPY
Cash and cash equivalents
1,769,786,000 JPY
1,711,449,000 JPY
1,711,320,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.